HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Er Jin Selected Research

LC capilliposide

1/2017Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Er Jin Research Topics

Disease

3Neoplasms (Cancer)
01/2020 - 01/2017
3Lung Neoplasms (Lung Cancer)
01/2019 - 11/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 11/2016
1Genomic Instability
11/2017
1Carcinogenesis
11/2016

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2019
2RetinoidsIBA
01/2019 - 11/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1Tumor Suppressor Protein p53IBA
11/2017
1LC capilliposideIBA
01/2017
1Gefitinib (Iressa)FDA Link
01/2017
1MicroRNAs (MicroRNA)IBA
11/2016
1Biomarkers (Surrogate Marker)IBA
11/2016